Overview
MIRM market data
Price History
MIRM price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for MIRM. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Arcutis Expands Board of Directors with Appointment of Chris PeetzGlobenewswire Inc · Jul 16, 2026, 1:15 PM
RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $148Benzinga · Jul 7, 2026, 4:25 PM
JP Morgan Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $125Benzinga · Jul 2, 2026, 2:35 PM
Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $146Benzinga · Jun 15, 2026, 2:15 PM
Morgan Stanley Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $150Benzinga · Jun 11, 2026, 12:24 PM
Mirum Pharmaceuticals And Incyte Announce That Phase 2 Results From The PROGRESS Study Evaluating Zilurgisertib In Patients With Fibrodysplasia Ossificans Progressiva Will Be Presented At The Endocrine Society Annual Meeting, June 13-16Benzinga · Jun 4, 2026, 12:15 PM
Citigroup Initiates Coverage On Mirum Pharmaceuticals with Buy Rating, Announces Price Target of $145Benzinga · Jun 2, 2026, 12:33 PM
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · May 19, 2026, 1:30 PM